Effectiveness and Cost-effectiveness of the Application of an Electronic Medication Management Support System in Patients With Polypharmacy in General Practice (AdAM).
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- BARMER
- 入组人数
- 12,000
- 试验地点
- 2
- 主要终点
- Combined endpoint of all-cause mortality and all-cause hospital admissions
研究概览
简要总结
This study assesses whether an electronic medication management support system improves quality, safety, and cost-effectiveness of the drug therapy in adult patients with polypharmacy compared to usual care during the observation period of 15 months from baseline per practice (from 2017 4th quarter to 2020 3rd quarter).
详细描述
Title:
Application of an electronic medication management support system.
Objectives:
The aim of the study is to assess the effectiveness of an electronic medication management support system on hospitalization and death, its cost-effectiveness and its effects on the quality and safety of prescribing in patients with polypharmacy.
Methods:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
盲法说明
Due to the character of the intervention, blinding is not possible.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years of age with polypharmacy (5 or more drugs taken for at least two quarters).
- •Informed consent.
排除标准
- •Incapacitated patients without legal representative
结局指标
主要结局
Combined endpoint of all-cause mortality and all-cause hospital admissions
时间窗: Observation period of 15 months per practice
The primary outcome is the combined endpoint of all-cause mortality and all-cause hospital admissions (including night- and day-only admissions) in patients with polypharmacy.
次要结局
- Number of potential inappropriate prescriptions(Observation period of 15 months per practice)
- All-cause hospital admissions(Observation period of 15 months per practice (quarterly))
- All-cause mortality(Observation period of 15 months per practice (quarterly))